bicalutamide has been researched along with dehydroepiandrosterone sulfate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eri, LM; Haug, E; Tveter, KJ | 1 |
| Flanagan, AM; Kendall, N; Lea, C | 1 |
| Bayram, F; Güven, M; Müderris, II; Ozçelik, B | 1 |
| Kagawa, M; Kawakami, S; Morozumi, M; Okada, Y; Takeshita, H; Yano, A | 1 |
1 trial(s) available for bicalutamide and dehydroepiandrosterone sulfate
| Article | Year |
|---|---|
Effects on the endocrine system of long-term treatment with the non-steroidal anti-androgen Casodex in patients with benign prostatic hyperplasia.
Topics: Aged; Androgen Antagonists; Androstenedione; Anilides; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Double-Blind Method; Estradiol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Nitriles; Prolactin; Prostatic Hyperplasia; Testosterone; Tosyl Compounds | 1995 |
3 other study(ies) available for bicalutamide and dehydroepiandrosterone sulfate
| Article | Year |
|---|---|
Casodex (a nonsteroidal antiandrogen) reduces cancellous, endosteal, and periosteal bone formation in estrogen-replete female rats.
Topics: Androgen Antagonists; Androgens; Anilides; Animals; Bone and Bones; Dehydroepiandrosterone Sulfate; Estrogens; Female; Nitriles; Osteogenesis; Rats; Rats, Sprague-Dawley; Tibia; Tosyl Compounds; Uterus; Weight Gain | 1996 |
New alternative treatment in hirsutism: bicalutamide 25 mg/day.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androgen Antagonists; Androstenedione; Anilides; Dehydroepiandrosterone Sulfate; Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Nitriles; Prolactin; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Tosyl Compounds | 2002 |
Baseline low serum dehydroepiandrosterone sulfate can predict poor responsiveness to hormone therapy in patients with hormone-naïve prostate cancer with skeletal metastases.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Bone Neoplasms; Dehydroepiandrosterone Sulfate; Humans; Male; Middle Aged; Nitriles; Predictive Value of Tests; Prostatic Neoplasms; Tosyl Compounds | 2017 |